The Federal Trade Commission on Tuesday ramped up the pressure on prescription-drug middlemen who influence the accessibility and affordability of medications.
Prescription-drug middlemen face more pressure from FTC in new report
Read Next
- ATFX Connect collaborates with Centroid to enhance liquidity and connectivity for Brokers
- RBI Guv to bank boards, ET BFSI
- Exploring Real Estate Tokenization: An Innovative Blockchain Approach
- 10 Things You Should Consider Before Buying Social Media Ads » Succeed As Your Own Boss
- 9 things in life you should really stop taking so personally, according to a psychologist
- How macroeconomic indicators performed in October 2024?, ET BFSI
- RBI prepares booklets in Santali language to create financial awareness among tribals, ET BFSI
